KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Invested Capital (2016 - 2025)

Cme (CME) has disclosed Invested Capital for 17 consecutive years, with $28.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital rose 5.48% to $28.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $28.7 billion, a 5.48% increase, with the full-year FY2025 number at $28.7 billion, up 5.48% from a year prior.
  • Invested Capital was $28.7 billion for Q4 2025 at Cme, up from $28.2 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $29.0 billion in Q3 2024 to a low of $45.4 million in Q2 2025.
  • A 5-year average of $17.1 billion and a median of $22.7 billion in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: soared 43830.16% in 2024, then tumbled 99.26% in 2025.
  • Cme's Invested Capital stood at $802.9 million in 2021, then plummeted by 89.95% to $80.7 million in 2022, then decreased by 23.17% to $62.0 million in 2023, then skyrocketed by 43830.16% to $27.2 billion in 2024, then grew by 5.48% to $28.7 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Invested Capital are $28.7 billion (Q4 2025), $28.2 billion (Q3 2025), and $45.4 million (Q2 2025).